CE vs SPRB · rev $10.28B vs rev $4.9M
Celanese Corporation (CE) versus Spruce Biosciences Inc (SPRB) — a side-by-side from cached financials, not a winner call.
Celanese Corporation (CE) is a chemicals company listed on US.
Spruce Biosciences Inc (SPRB) is a biotechnology company listed on US.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
Latest reported SPRB revenue for 2024-12-31 was $4.9M. Net income was -$53.0M. Revenue was down 51.3% from 2023-12-31 to 2024-12-31. SPRB currently screens at market cap $3.0M.
CE currently screens at market cap $5.92B. SPRB currently screens at market cap $3.0M.
Not investment advice. Open the CE and SPRB stock pages for the full models.
Not investment advice.